A detailed history of True Private Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, True Private Wealth Advisors holds 8,985 shares of LLY stock, worth $8.13 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
8,985
Previous 9,088 1.13%
Holding current value
$8.13 Million
Previous $5.3 Million 31.94%
% of portfolio
0.82%
Previous 0.68%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $60,996 - $81,604
-103 Reduced 1.13%
8,985 $6.99 Million
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $16,806 - $19,812
32 Added 0.35%
9,088 $5.3 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $244,301 - $336,806
-562 Reduced 5.84%
9,056 $4.86 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $491,036 - $656,572
-1,400 Reduced 12.71%
9,618 $4.51 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $251,920 - $295,869
-811 Reduced 6.86%
11,018 $3.78 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $25,402 - $29,598
-79 Reduced 0.66%
11,829 $4.33 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $45,954 - $52,369
155 Added 1.32%
11,908 $3.85 Million
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $186,749 - $219,270
670 Added 6.05%
11,753 $3.81 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $3,755 - $4,666
16 Added 0.14%
11,083 $3.27 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $3,372 - $4,185
15 Added 0.14%
11,067 $3.06 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $257,720 - $317,161
-1,163 Reduced 9.52%
11,052 $2.55 Million
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $5,235 - $6,772
-29 Reduced 0.24%
12,215 $2.8 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $205,892 - $266,538
-1,253 Reduced 9.28%
12,244 $2.29 Million
Q4 2020

Jan 11, 2021

SELL
$130.46 - $172.63 $10,958 - $14,500
-84 Reduced 0.62%
13,497 $2.28 Million
Q3 2020

Oct 09, 2020

BUY
$146.22 - $169.13 $6,287 - $7,272
43 Added 0.32%
13,581 $2.01 Million
Q2 2020

Jul 07, 2020

SELL
$136.42 - $164.18 $415,808 - $500,420
-3,048 Reduced 18.38%
13,538 $2.22 Million
Q1 2020

Apr 20, 2020

BUY
$119.05 - $147.35 $171,908 - $212,773
1,444 Added 9.54%
16,586 $2.3 Million
Q4 2019

Jan 27, 2020

SELL
$106.92 - $132.43 $213,840 - $264,860
-2,000 Reduced 11.67%
15,142 $1.99 Million
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $1,772 - $2,069
-16 Reduced 0.09%
17,142 $1.9 Million
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $25,044 - $29,479
-225 Reduced 1.29%
17,158 $2.23 Million
Q4 2018

Jan 14, 2019

SELL
$105.9 - $118.64 $1,059 - $1,186
-10 Reduced 0.06%
17,383 $2.01 Million
Q3 2018

Oct 18, 2018

BUY
$85.86 - $107.31 $4,121 - $5,150
48 Added 0.28%
17,393 $0
Q2 2018

Jul 13, 2018

SELL
$75.7 - $86.88 $16,881 - $19,374
-223 Reduced 1.27%
17,345 $1.48 Million
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $427,449 - $504,575
-5,760 Reduced 24.69%
17,568 $1.36 Million
Q4 2017

Jan 19, 2018

SELL
$81.94 - $87.89 $32,284 - $34,628
-394 Reduced 1.66%
23,328 $1.97 Million
Q3 2017

Oct 27, 2017

BUY
$77.07 - $85.54 $664,035 - $737,012
8,616 Added 57.04%
23,722 $2.03 Million
Q2 2017

Aug 07, 2017

BUY
N/A
15,106
15,106 $1.24 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.